*ST Jiyou (603429.SH) plans to acquire 50.76% of Huiju Pharmaceutical's shares for 1,006 billion yuan

Zhitong Finance App News, *ST Jiyou (603429.SH) announced that the company plans to purchase 50.76% of the total shares of Jiangsu Huiju Pharmaceutical Co., Ltd. from Huang Hua, Zou Ping, Bi Weiguo, Nantong Huiping, and Nantong Huiyuan through cash payment. After the transaction is completed, Huiju Pharmaceutical will become the company's holding subsidiary, with a transaction price of about 1.06 billion yuan.

Before the transaction was completed, the company was mainly engaged in the production and sale of products such as packaging and printed products, anodized aluminum and composite paper. Huiju Pharmaceutical focuses on R&D, production and sales of complex small-molecule chemical drugs, polypeptide drugs, and key intermediates, specialty APIs and formulations for nucleic acid drugs. It provides customers with customized R&D and production (CDMO) services, and relies on self-developed pharmaceutical technology to carry out technology transfer, joint development and commercialization revenue sharing cooperation.

After the transaction is completed, Huiju Pharmaceutical will become the company's holding subsidiary, and the company will expand from the packaging and printing industry to the pharmaceutical manufacturing industry; the target company has good profitability and business prospects. The transaction will help the company further expand the company's future growth space, enhance the company's ability to continue operating, enhance its core competitiveness, and effectively safeguard the interests of the company's small and medium shareholders.